0000891092-21-003306.txt : 20210405 0000891092-21-003306.hdr.sgml : 20210405 20210405161957 ACCESSION NUMBER: 0000891092-21-003306 CONFORMED SUBMISSION TYPE: 424B2 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20210405 DATE AS OF CHANGE: 20210405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JPMORGAN CHASE & CO CENTRAL INDEX KEY: 0000019617 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 132624428 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B2 SEC ACT: 1933 Act SEC FILE NUMBER: 333-236659 FILM NUMBER: 21805609 BUSINESS ADDRESS: STREET 1: 383 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2122706000 MAIL ADDRESS: STREET 1: 383 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: J P MORGAN CHASE & CO DATE OF NAME CHANGE: 20010102 FORMER COMPANY: FORMER CONFORMED NAME: CHASE MANHATTAN CORP /DE/ DATE OF NAME CHANGE: 19960402 FORMER COMPANY: FORMER CONFORMED NAME: CHEMICAL BANKING CORP DATE OF NAME CHANGE: 19920703 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JPMorgan Chase Financial Co. LLC CENTRAL INDEX KEY: 0001665650 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 475462128 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B2 SEC ACT: 1933 Act SEC FILE NUMBER: 333-236659-01 FILM NUMBER: 21805610 BUSINESS ADDRESS: STREET 1: 383 MADISON AVENUE STREET 2: FLOOR 21 CITY: NEW YORK STATE: NY ZIP: 10179 BUSINESS PHONE: (212) 270-6000 MAIL ADDRESS: STREET 1: 383 MADISON AVENUE STREET 2: FLOOR 21 CITY: NEW YORK STATE: NY ZIP: 10179 424B2 1 e13200-424b2.htm PRICING SUPPLEMENT

 

JPMorgan Chase Financial Company LLC April 2021
  Pricing Supplement
  Registration Statement Nos. 333-236659 and 333-236659-01
  Dated April 1, 2021
  Filed pursuant to Rule 424(b)(2)

Structured Investments

Opportunities in U.S. Equities

Contingent Income Auto-Callable Securities due April 4, 2024

Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.

Contingent Income Auto-Callable Securities do not guarantee the payment of interest or the repayment of principal. Instead, the securities offer the opportunity for investors to earn a contingent quarterly payment equal to 1.9375% of the stated principal amount with respect to each determination date on which the closing price of the underlying stock is greater than or equal to 80% of the initial stock price, which we refer to as the downside threshold level. However, if, on any determination date, the closing price of the underlying stock is less than the downside threshold level, you will not receive any contingent quarterly payment for the related quarterly period. In addition, if the closing price of the underlying stock is greater than or equal to the initial stock price on any determination date (other than the first and final determination dates), the securities will be automatically redeemed for an amount per security equal to the stated principal amount plus the contingent quarterly payment with respect to that determination date. If the securities have not been automatically redeemed prior to maturity and the final stock price is greater than or equal to the downside threshold level, the payment at maturity due on the securities will be the stated principal amount and the contingent quarterly payment with respect to the final determination date. If, however, the securities have not been automatically redeemed prior to maturity and the final stock price is less than the downside threshold level, you will be exposed to the decline in the underlying stock, as compared to the initial stock price, on a 1-to-1 basis and will receive a cash payment at maturity that is less than 80% of the stated principal amount of the securities and could be zero. The securities are for investors who are willing to risk their principal and seek an opportunity to earn interest at a potentially above-market rate in exchange for the risk of receiving few or no contingent quarterly payments and also the risk of receiving a cash payment at maturity that is significantly less than the stated principal amount of the securities and could be zero. Accordingly, investors could lose their entire initial investment in the securities. Investors will not participate in any appreciation of the underlying stock. The securities are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co., issued as part of JPMorgan Financial’s Medium-Term Notes, Series A, program. Any payment on the securities is subject to the credit risk of JPMorgan Financial, as issuer of the securities, and the credit risk of JPMorgan Chase & Co., as guarantor of the securities.

FINAL TERMS  
Issuer: JPMorgan Chase Financial Company LLC, an indirect, wholly owned finance subsidiary of JPMorgan Chase & Co.
Guarantor: JPMorgan Chase & Co.
Underlying stock: Common stock of Amgen Inc. (Bloomberg ticker: AMGN UW Equity)
Aggregate principal amount: $970,000
Early redemption:

If, on any determination date (other than the first and final determination dates), the closing price of the underlying stock is greater than or equal to the initial stock price, the securities will be automatically redeemed for an early redemption payment on the first contingent payment date immediately following the related determination date. No further payments will be made on the securities once they have been redeemed.

The securities will not be redeemed early on any contingent payment date if the closing price of the underlying stock is below the initial stock price on the related determination date.

Early redemption payment: The early redemption payment will be an amount equal to (i) the stated principal amount plus (ii) the contingent quarterly payment with respect to the related determination date.

Contingent quarterly payment: · If, on any determination date, the closing price of the underlying stock is greater than or equal to the downside threshold level, we will pay a contingent quarterly payment of $0.1938 (1.9375% of the stated principal amount) per security on the related contingent payment date.
  · If, on any determination date, the closing price of the underlying stock is less than the downside threshold level, no contingent quarterly payment will be made with respect to that determination date. It is possible that the closing price of the underlying stock will be below the downside threshold level on most or all of the determination dates so that you will receive few or no contingent quarterly payments.

Determination dates: July 1, 2021, October 1, 2021, January 3, 2022, April 1, 2022, July 1, 2022, October 3, 2022, January 3, 2023, April 3, 2023, July 3, 2023, October 2, 2023, January 2, 2024 and April 1, 2024, subject to postponement for non-trading days and certain market disruption events
Contingent payment dates: July 7, 2021, October 6, 2021, January 6, 2022, April 6, 2022, July 7, 2022, October 6, 2022, January 6, 2023, April 6, 2023, July 7, 2023, October 5, 2023, January 5, 2024 and the maturity date, subject to postponement in the event of certain market disruption events and as described under “General Terms of the Notes — Postponement of Payment Date” in the accompanying product supplement

Payment at maturity: · If the final stock price is greater than or equal to the downside threshold level: (i) the stated principal amount plus (ii) the contingent quarterly payment with respect to the final determination date
  ·  If the final stock price is less than the downside threshold level: (i) the stated principal amount times (ii) the stock performance factor.  This cash payment will be less than 80% of the stated principal amount of the securities and could be zero.

Downside threshold level: $199.336, which is equal to 80% of the initial stock price
Initial stock price: $249.17, which was the closing price of the underlying stock on the pricing date
Final stock price: The closing price of the underlying stock on the final determination date
Stock adjustment factor: The stock adjustment factor is referenced in determining the closing price of the underlying stock and is set initially at 1.0 on the pricing date.  The stock adjustment factor is subject to adjustment in the event of certain corporate events affecting the underlying stock.
Stock performance factor: final stock price / initial stock price
Stated principal amount: $10 per security
Issue price: $10 per security (see “Commissions and issue price” below)
Pricing date: April 1, 2021
Original issue date (settlement date): April 7, 2021
Maturity date: April 4, 2024, subject to postponement in the event of certain market disruption events and as described under “General Terms of Notes — Postponement of a Payment Date” in the accompanying product supplement
CUSIP/ISIN: 48132V622 / US48132V6222
Listing: The securities will not be listed on any securities exchange.
Agent: J.P. Morgan Securities LLC (“JPMS”)
Commissions and issue price:   Price to public(1) Fees and commissions Proceeds to issuer
Per security   $10.00 $0.20(2) $9.75
      $0.05(3)  

Total   $970,000.00 $24,250.00 $945,750.00
(1)See “Additional Information about the Securities — Supplemental use of proceeds and hedging” in this document for information about the components of the price to public of the securities.
(2)JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of $0.20 per $10 stated principal amount security it receives from us to Morgan Stanley Smith Barney LLC (“Morgan Stanley Wealth Management”). See “Plan of Distribution (Conflicts of Interest)” in the accompanying product supplement.
(3)Reflects a structuring fee payable to Morgan Stanley Wealth Management by the agent or its affiliates of $0.05 for each $10 stated principal amount security

The estimated value of the securities on the pricing date was $9.524 per $10 stated principal amount security. See “Additional Information about the Securities — The estimated value of the securities” in this document for additional information.

Investing in the securities involves a number of risks. See “Risk Factors” beginning on page S-2 of the accompanying prospectus supplement, “Risk Factors” beginning on page PS-12 of the accompanying product supplement and “Risk Factors” beginning on page 9 of this document.

Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the securities or passed upon the accuracy or the adequacy of this document or the accompanying product supplement, prospectus supplement and prospectus. Any representation to the contrary is a criminal offense.

The securities are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.

You should read this document together with the related product supplement, prospectus supplement and prospectus, each of which can be accessed via the hyperlinks below. Please also see “Additional Information about the Securities” at the end of this document.

Product supplement no. MS-1-II dated November 4, 2020: http://www.sec.gov/Archives/edgar/data/19617/000095010320021469/crt_dp139325-424b2.pdf

Prospectus supplement and prospectus, each dated April 8, 2020: http://www.sec.gov/Archives/edgar/data/19617/000095010320007214/crt_dp124361-424b2.pdf

 

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

Investment Summary

The Contingent Income Auto-Callable Securities due April 4, 2024 Based on the Performance of the Common Stock of Amgen Inc., which we refer to as the securities, do not provide for the regular payment of interest. Instead, the securities provide an opportunity for investors to earn a contingent quarterly payment, which is an amount equal to $0.1938 (1.9375% of the stated principal amount) per security, with respect to each quarterly determination date on which the closing price of the underlying stock is greater than or equal to 80% of the initial stock price, which we refer to as the downside threshold level. The contingent quarterly payment, if any, will be payable quarterly on the contingent payment date immediately following the related determination date. However, if the closing price of the underlying stock is less than the downside threshold level on any determination date, investors will receive no contingent quarterly payment for the related quarterly period. It is possible that the closing price of the underlying stock could be below the downside threshold level on most or all of the determination dates so that you will receive few or no contingent quarterly payments during the term of the securities. We refer to these payments as contingent, because there is no guarantee that you will receive a payment on any contingent payment date. Even if the underlying stock was at or above the downside threshold level on some quarterly determination dates, the underlying stock may fluctuate below the downside threshold level on others.

If the closing price of the underlying stock is greater than or equal to the initial stock price on any determination date (other than the first and final determination dates), the securities will be automatically redeemed for an early redemption payment equal to the stated principal amount plus the contingent quarterly payment with respect to the related determination date. If the securities have not previously been redeemed and the final stock price is greater than or equal to the downside threshold level, the payment at maturity will also be the sum of the stated principal amount and the contingent quarterly payment with respect to the final determination date. However, if the securities have not previously been redeemed and the final stock price is less than the downside threshold level, investors will be exposed to the decline in the closing price of the underlying stock, as compared to the initial stock price, on a 1-to-1 basis. Under these circumstances, the payment at maturity will be (i) the stated principal amount times (ii) the stock performance factor, which will be less than 80% of the stated principal amount of the securities and could be zero. Investors in the securities must be willing to accept the risk of losing their entire principal and also the risk of receiving few or no contingent quarterly payments over the term of the securities. In addition, investors will not participate in any appreciation of the underlying stock.

Supplemental Terms of the Securities

For purposes of the accompanying product supplement, the underlying stock is a “Reference Stock.”

April 2021Page 2

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

Key Investment Rationale

The securities do not provide for the regular payment of interest. Instead, the securities offer investors an opportunity to earn a contingent quarterly payment equal to 1.9375% of the stated principal amount with respect to each determination date on which the closing price of the underlying stock is greater than or equal to 80% of the initial stock price, which we refer to as the downside threshold level. The securities may be redeemed prior to maturity for the stated principal amount per security plus the applicable contingent quarterly payment, and the payment at maturity will vary depending on the final stock price, as follows:

 

Scenario 1

On any determination date (other than the first and final determination dates), the closing price of the underlying stock is greater than or equal to the initial stock price.

■     The securities will be automatically redeemed for (i) the stated principal amount plus (ii) the contingent quarterly payment with respect to the related determination date.

■     Investors will not participate in any appreciation of the underlying stock from the initial stock price.

Scenario 2

The securities are not automatically redeemed prior to maturity, and the final stock price is greater than or equal to the downside threshold level.

■     The payment due at maturity will be (i) the stated principal amount plus (ii) the contingent quarterly payment with respect to the final determination date.

■     Investors will not participate in any appreciation of the underlying stock from the initial stock price.

Scenario 3

The securities are not automatically redeemed prior to maturity, and the final stock price is less than the downside threshold level.

■     The payment due at maturity will be (i) the stated principal amount times (ii) the stock performance factor.

■     Investors will lose some, and may lose all, of their principal in this scenario.

 

April 2021Page 3

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

How the Securities Work

The following diagrams illustrate the potential outcomes for the securities depending on (1) the closing price of the underlying stock and (2) the final stock price.

Diagram #1: First Determination Date

 

Diagram #2: Determination Dates (Other Than the First and Final Determination Dates)

 

April 2021Page 4

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

Diagram #3: Payment at Maturity if No Automatic Early Redemption Occurs

 

For more information about the payment upon an early redemption or at maturity in different hypothetical scenarios, see “Hypothetical Examples” starting on page 6.

April 2021Page 5

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

Hypothetical Examples

The below examples are based on the following terms:

Stated principal amount: $10 per security
Hypothetical initial stock price: $100.00
Hypothetical downside threshold level: $80.00, which is 80% of the hypothetical initial stock price
Hypothetical stock adjustment factor: 1.0
Contingent quarterly payment: $0.1938 (1.9375% of the stated principal amount) per security

The hypothetical initial stock price of $100.00 has been chosen for illustrative purposes only and does not represent the actual initial stock price.  The actual initial stock price is the closing price of the underlying stock on the pricing date and is specified on the cover of this pricing supplement. For historical data regarding the actual closing prices of the underlying stock, please see the historical information set forth under “Amgen Inc. Overview” in this pricing supplement.

In Examples 1 and 2, the closing price of the underlying stock fluctuates over the term of the securities and the closing price of the underlying stock is greater than or equal to the initial stock price on one of the determination dates (other than the final determination date). Because the closing price of the underlying stock is greater than or equal to the initial stock price on one of the determination dates (other than the final determination date), the securities are automatically redeemed following the relevant determination date. In Examples 3 and 4, the closing price of the underlying stock on the determination dates (other than the final determination date) is less than the initial stock price, and, consequently, the securities are not automatically redeemed prior to, and remain outstanding until, maturity.

  Example 1 Example 2
Determination Dates Hypothetical Closing Price Contingent Quarterly
Payment		 Early Redemption Payment* Hypothetical Closing Price Contingent Quarterly Payment Early Redemption Payment*
#1 $65.00 $0 N/A $105.00 $0.1938 N/A
#2 $100.00 —* $10.1938 $50.00 $0 N/A
#3 N/A N/A N/A $60.00 $0 N/A
#4 N/A N/A N/A $65.00 $0 N/A
#5 N/A N/A N/A $80.00 $0.1938 N/A
#6 N/A N/A N/A $85.00 $0.1938 N/A
#7 N/A N/A N/A $65.00 $0 N/A
#8 N/A N/A N/A $95.00 $0.1938 N/A
#9 N/A N/A N/A $80.00 $0.1938 N/A
#10 N/A N/A N/A $125.00 —* $10.1938
#11 N/A N/A N/A N/A N/A N/A
Final Determination Date N/A N/A N/A N/A N/A N/A

* The early redemption payment includes the unpaid contingent quarterly payment with respect to the determination date on which the closing price is greater than or equal to the initial stock price and the securities are redeemed as a result.

 

 

■In Example 1, the securities are automatically redeemed following the second determination date as the closing price of the underlying stock on the second determination date is equal to the initial stock price. As the closing price of the underlying stock on the first determination date is less than the downside threshold level, no contingent quarterly payment was made with respect to that date. Following the second determination date, you receive the early redemption payment, calculated as follows:

stated principal amount + contingent quarterly payment = $10 + $0.1938 = $10.1938

In this example, the early redemption feature limits the term of your investment to approximately 6 months and you may not be able to reinvest at comparable terms or returns. If the securities are redeemed early, you will stop receiving contingent quarterly payments.

April 2021Page 6

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

■In Example 2, the securities are automatically redeemed following the tenth determination date as the closing price of the underlying stock on the tenth determination date is greater than the initial stock price. The securities are not redeemable on the first determination date, even though the closing price of the underlying stock on the first determination date is greater than the initial stock price. As the closing price of the underlying stock on each of the first, fifth, sixth, eighth and ninth determination dates is greater than the downside threshold level, you receive the contingent quarterly payment of $0.1938 with respect to each of those determination dates. Following the tenth determination date, you receive an early redemption payment of $10.1938, which includes the contingent quarterly payment with respect to the tenth determination date.

In this example, the early redemption feature limits the term of your investment to approximately 30 months and you may not be able to reinvest at comparable terms or returns. If the securities are redeemed early, you will stop receiving contingent quarterly payments. Further, although the underlying stock has appreciated by 25% from the initial stock price on the tenth determination date, you only receive $10.1938 per security upon redemption and do not benefit from this appreciation. The total payments on the securities will amount to $11.1628 per security.

 

  Example 3 Example 4
Determination Dates Hypothetical Closing Price Contingent Quarterly
Payment		 Early Redemption Payment Hypothetical Closing Price Contingent Quarterly Payment Early Redemption Payment
#1 $65.00 $0 N/A $45.00 $0 N/A
#2 $55.00 $0 N/A $60.00 $0 N/A
#3 $50.00 $0 N/A $57.50 $0 N/A
#4 $55.00 $0 N/A $65.00 $0 N/A
#5 $45.00 $0 N/A $67.50 $0 N/A
#6 $40.00 $0 N/A $60.00 $0 N/A
#7 $45.00 $0 N/A $65.00 $0 N/A
#8 $55.00 $0 N/A $55.00 $0 N/A
#9 $62.50 $0 N/A $45.00 $0 N/A
#10 $50.00 $0 N/A $67.50 $0 N/A
#11 $65.00 $0 N/A $65.00 $0 N/A
Final Determination Date $40.00 $0 N/A $80.00 —* N/A
Payment at Maturity $4.00 $10.1938

* The final contingent quarterly payment, if any, will be paid at maturity.

 

Examples 3 and 4 illustrate the payment at maturity per security based on the final stock price.

■In Example 3, the closing price of the underlying stock remains below the downside threshold level throughout the term of the securities. As a result, you do not receive any contingent quarterly payment during the term of the securities and, at maturity, you are fully exposed to the decline in the closing price of the underlying stock. As the final stock price is less than the downside threshold level, you receive a cash payment at maturity calculated as follows:

stated principal amount × stock performance factor = $10 × $40.00 / $100.00 = $4.00

In this example, the payment you receive at maturity is significantly less than the stated principal amount.

■In Example 4, the closing price of the underlying stock decreases to a final stock price of $75.00. Although the final stock price is less than the initial stock price, because the final stock price is still not less than the downside threshold level, you receive the stated principal amount plus a contingent quarterly payment with respect to the final determination date. Your payment at maturity is calculated as follows:

$10 + $0.1938 = $10.1938

April 2021Page 7

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

In this example, although the final stock price represents a 20% decline from the initial stock price, you receive the stated principal amount per security plus the contingent quarterly payment, equal to a total payment of $10.1938 per security at maturity.

The hypothetical returns and hypothetical payments on the securities shown above apply only if you hold the securities for their entire term or until early redemption. These hypotheticals do not reflect fees or expenses that would be associated with any sale in the secondary market. If these fees and expenses were included, the hypothetical returns and hypothetical payments shown above would likely be lower.

April 2021Page 8

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

Risk Factors

The following is a non-exhaustive list of certain key risk factors for investors in the securities. For further discussion of these and other risks, you should read the sections entitled “Risk Factors” of the accompanying prospectus supplement and the accompanying product supplement. We urge you to consult your investment, legal, tax, accounting and other advisers in connection with your investment in the securities.

Risks Relating to the Securities Generally

■The securities do not guarantee the return of any principal and your investment in the securities may result in a loss. The terms of the securities differ from those of ordinary debt securities in that the securities do not guarantee the return of any of the principal amount at maturity. Instead, if the securities have not been automatically redeemed prior to maturity and if the final stock price is less than the downside threshold level, you will be exposed to the decline in the closing price of the underlying stock, as compared to the initial stock price, on a 1-to-1 basis and you will receive for each security that you hold at maturity a cash payment equal to the stated principal amount times the stock performance factor. In this case, your payment at maturity will be less than 80% of the stated principal amount and could be zero.
■You will not receive any contingent quarterly payment for any quarterly period if the closing price of the underlying stock on the relevant determination date is less than the downside threshold level. The terms of the securities differ from those of ordinary debt securities in that the securities do not guarantee the payment of regular interest. Instead, a contingent quarterly payment will be made with respect to a quarterly period only if the closing price of the underlying stock on the relevant determination date is greater than or equal to the downside threshold level. If the closing price of the underlying stock is below the downside threshold level on any determination date, you will not receive a contingent quarterly payment for the relevant quarterly period. It is possible that the closing price of the underlying stock could be below the downside threshold level on most or all of the determination dates so that you will receive few or no contingent quarterly payments. If you do not earn sufficient contingent quarterly payments over the term of the securities, the overall return on the securities may be less than the amount that would be paid on one of our conventional debt securities of comparable maturity.
■The contingent quarterly payment is based solely on the closing prices of the underlying stock on the specified determination dates. Whether the contingent quarterly payment will be made with respect to a determination date will be based on the closing price of the underlying stock on that determination date. As a result, you will not know whether you will receive the contingent quarterly payment until the related determination date. Moreover, because the contingent quarterly payment is based solely on the closing price of the underlying stock on a specific determination date, if that closing price is less than the downside threshold level, you will not receive any contingent quarterly payment with respect to that determination date, even if the closing price of the underlying stock was higher on other days during the term of the securities.
■The securities are subject to the credit risks of JPMorgan Financial and JPMorgan Chase & Co., and any actual or anticipated changes to our or JPMorgan Chase & Co.’s credit ratings or credit spreads may adversely affect the market value of the securities. Investors are dependent on our and JPMorgan Chase & Co.’s ability to pay all amounts due on the securities. Any actual or anticipated decline in our or JPMorgan Chase & Co.’s credit ratings or increase in our or JPMorgan Chase & Co.’s credit spreads determined by the market for taking that credit risk is likely to adversely affect the market value of the securities. If we and JPMorgan Chase & Co. were to default on our payment obligations, you may not receive any amounts owed to you under the securities and you could lose your entire investment.
■As a finance subsidiary, JPMorgan Financial has no independent operations and has limited assets. As a finance subsidiary of JPMorgan Chase & Co., we have no independent operations beyond the issuance and administration of our securities. Aside from the initial capital contribution from JPMorgan Chase & Co., substantially all of our assets relate to obligations of our affiliates to make payments under loans made by us or other intercompany agreements. As a result, we are dependent upon payments from our affiliates to meet our obligations under the securities. If these affiliates do not make payments to us and we fail to make payments on the securities, you may have to seek payment under the related guarantee by JPMorgan Chase & Co., and that guarantee will rank pari passu with all other unsecured and unsubordinated obligations of JPMorgan Chase & Co.
■Investors will not participate in any appreciation of the underlying stock. Investors will not participate in any appreciation of the underlying stock from the initial stock price, and the return on the securities will be limited to the contingent quarterly payment that is paid with respect to each determination date on which the closing price is greater than or equal to the downside threshold level, if any.

April 2021Page 9

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

■Early redemption risk. The term of your investment in the securities may be limited to as short as approximately six months by the automatic early redemption feature of the securities. If the securities are redeemed prior to maturity, you will receive no more contingent quarterly payments and may be forced to reinvest in a lower interest rate environment and you may not be able to reinvest the proceeds from an investment in the securities at a comparable return for a similar level of risk.
■Secondary trading may be limited. The securities will not be listed on a securities exchange. There may be little or no secondary market for the securities. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the securities easily. JPMS may act as a market maker for the securities, but is not required to do so. Because we do not expect that other market makers will participate significantly in the secondary market for the securities, the price at which you may be able to trade your securities is likely to depend on the price, if any, at which JPMS is willing to buy the securities. If at any time JPMS or another agent does not act as a market maker, it is likely that there would be little or no secondary market for the securities.
■The U.S. federal income tax consequences of an investment in the securities are uncertain. There is no direct legal authority as to the proper U.S. federal income tax treatment of the securities, and we do not intend to request a ruling from the IRS. The IRS might not accept, and a court might not uphold, the treatment of the securities as prepaid forward contracts with associated contingent coupons, as described in “Additional Information about the Securities — Additional Provisions — Tax considerations” in this document and in “Material U.S. Federal Income Tax Consequences” in the accompanying product supplement. If the IRS were successful in asserting an alternative treatment for the securities, the timing and character of any income or loss on the securities could be materially affected. Although the U.S. federal income tax treatment of contingent quarterly payments (including any contingent quarterly payments paid in connection with an early redemption or at maturity) is uncertain, in determining our reporting responsibilities we intend (in the absence of an administrative determination or judicial ruling to the contrary) to treat any contingent quarterly payments as ordinary income. In addition, in 2007 Treasury and the IRS released a notice requesting comments on the U.S. federal income tax treatment of “prepaid forward contracts” and similar instruments. The notice focuses in particular on whether to require investors in these instruments to accrue income over the term of their investment. It also asks for comments on a number of related topics, including the character of income or loss with respect to these instruments and the relevance of factors such as the nature of the underlying property to which the instruments are linked. While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially affect the tax consequences of an investment in the securities, possibly with retroactive effect. You should review carefully the section entitled “Material U.S. Federal Income Tax Consequences” in the accompanying product supplement and consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the securities, including possible alternative treatments and the issues presented by this notice.

Non-U.S. Holders — Tax Consideration. The U.S. federal income tax treatment of contingent quarterly payments is uncertain, and although we believe it is reasonable to take a position that contingent quarterly payments are not subject to U.S. withholding tax (at least if an applicable Form W-8 is provided), a withholding agent may nonetheless withhold on these payments (generally at a rate of 30%, subject to the possible reduction of that rate under an applicable income tax treaty), unless income from your securities is effectively connected with your conduct of a trade or business in the United States (and, if an applicable treaty so requires, attributable to a permanent establishment in the United States). In the event of any withholding, we will not be required to pay any additional amounts with respect to amounts so withheld. If you are not a United States person, you are urged to consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the securities in light of your particular circumstances.

Risks Relating to Conflicts of Interest

■Economic interests of the issuer, the guarantor, the calculation agent, the agent of the offering of the securities and other affiliates of the issuer may be different from those of investors. We and our affiliates play a variety of roles in connection with the issuance of the securities, including acting as calculation agent and as an agent of the offering of the securities, hedging our obligations under the securities and making the assumptions used to determine the pricing of the securities and the estimated value of the securities, which we refer to as the estimated value of the securities. In performing these duties, our and JPMorgan Chase & Co.’s economic interests and the economic interests of the calculation agent and other affiliates of ours are potentially adverse to your interests as an investor in the securities. The calculation agent has determined the initial stock price and the downside threshold level and will determine the final stock price and whether the closing price of the underlying stock on any determination date is greater than or equal to the initial stock price or is below the downside threshold level. Determinations made by the calculation agent, including with respect to the occurrence or non-occurrence of market disruption events, may affect the payment to you at maturity or whether the securities are redeemed early.

In addition, our and JPMorgan Chase & Co.’s business activities, including hedging and trading activities, could cause our and JPMorgan Chase & Co.’s economic interests to be adverse to yours and could adversely affect any

April 2021Page 10

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

payment on the securities and the value of the securities. It is possible that hedging or trading activities of ours or our affiliates in connection with the securities could result in substantial returns for us or our affiliates while the value of the securities declines. Please refer to “Risk Factors — Risks Relating to Conflicts of Interest” in the accompanying product supplement for additional information about these risks.

■Hedging and trading activities by the issuer and its affiliates could potentially affect the value of the securities. The hedging or trading activities of the issuer’s affiliates and of any other hedging counterparty with respect to the securities on or prior to the pricing date and prior to maturity could have adversely affected, and may continue to adversely affect, the value of the underlying stock. Any of these hedging or trading activities on or prior to the pricing date could have affected the initial stock price and, as a result, the downside threshold level, which is the price at or above which the underlying stock must close on each determination date in order for you to earn a contingent quarterly payment or, if the securities are not redeemed prior to maturity, in order for you to avoid being exposed to the negative price performance of the underlying stock at maturity. Additionally, these hedging or trading activities during the term of the securities could potentially affect the price of the underlying stock on the determination dates and, accordingly, whether investors will receive one or more contingent quarterly payments, whether the securities are automatically redeemed prior to maturity and, if the securities are not redeemed prior to maturity, the payment to you at maturity. It is possible that these hedging or trading activities could result in substantial returns for us or our affiliates while the value of the securities declines.

Risks Relating to the Estimated Value and Secondary Market Prices of the Securities

■The estimated value of the securities is lower than the original issue price (price to public) of the securities. The estimated value of the securities is only an estimate determined by reference to several factors. The original issue price of the securities exceeds the estimated value of the securities because costs associated with selling, structuring and hedging the securities are included in the original issue price of the securities. These costs include the selling commissions, the structuring fee, the projected profits, if any, that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the securities and the estimated cost of hedging our obligations under the securities. See “Additional Information about the Securities — The estimated value of the securities” in this document.
■The estimated value of the securities does not represent future values of the securities and may differ from others’ estimates. The estimated value of the securities is determined by reference to internal pricing models of our affiliates. This estimated value of the securities is based on market conditions and other relevant factors existing at the time of pricing and assumptions about market parameters, which can include volatility, dividend rates, interest rates and other factors. Different pricing models and assumptions could provide valuations for the securities that are greater than or less than the estimated value of the securities. In addition, market conditions and other relevant factors in the future may change, and any assumptions may prove to be incorrect. On future dates, the value of the securities could change significantly based on, among other things, changes in market conditions, our or JPMorgan Chase & Co.’s creditworthiness, interest rate movements and other relevant factors, which may impact the price, if any, at which JPMS would be willing to buy securities from you in secondary market transactions. See “Additional Information about the Securities — The estimated value of the securities” in this document.
■The estimated value of the securities is derived by reference to an internal funding rate. The internal funding rate used in the determination of the estimated value of the securities may differ from the market-implied funding rate for vanilla fixed income instruments of a similar maturity issued by JPMorgan Chase & Co. or its affiliates. Any difference may be based on, among other things, our and our affiliates’ view of the funding value of the securities as well as the higher issuance, operational and ongoing liability management costs of the securities in comparison to those costs for the conventional fixed income instruments of JPMorgan Chase & Co. This internal funding rate is based on certain market inputs and assumptions, which may prove to be incorrect, and is intended to approximate the prevailing market replacement funding rate for the securities. The use of an internal funding rate and any potential changes to that rate may have an adverse effect on the terms of the securities and any secondary market prices of the securities. See “Additional Information about the Securities — The estimated value of the securities” in this document.
■The value of the securities as published by JPMS (and which may be reflected on customer account statements) may be higher than the then-current estimated value of the securities for a limited time period. We generally expect that some of the costs included in the original issue price of the securities will be partially paid back to you in connection with any repurchases of your securities by JPMS in an amount that will decline to zero over an initial predetermined period. These costs can include selling commissions, the structuring fee, projected hedging profits, if any, and, in some circumstances, estimated hedging costs and our internal secondary market funding rates for structured debt issuances. See “Additional Information about the Securities — Secondary market prices of the securities” in this document for additional information relating to this initial period. Accordingly, the estimated value of

April 2021Page 11

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

your securities during this initial period may be lower than the value of the securities as published by JPMS (and which may be shown on your customer account statements).

■Secondary market prices of the securities will likely be lower than the original issue price of the securities. Any secondary market prices of the securities will likely be lower than the original issue price of the securities because, among other things, secondary market prices take into account our internal secondary market funding rates for structured debt issuances and, also, because secondary market prices may exclude selling commissions, the structuring fee, projected hedging profits, if any, and estimated hedging costs that are included in the original issue price of the securities. As a result, the price, if any, at which JPMS will be willing to buy securities from you in secondary market transactions, if at all, is likely to be lower than the original issue price. Any sale by you prior to the maturity date could result in a substantial loss to you. See the immediately following risk factor for information about additional factors that will impact any secondary market prices of the securities.

The securities are not designed to be short-term trading instruments. Accordingly, you should be able and willing to hold your securities to maturity. See “— Secondary trading may be limited” below.

■Secondary market prices of the securities will be impacted by many economic and market factors.  The secondary market price of the securities during their term will be impacted by a number of economic and market factors, which may either offset or magnify each other, aside from the selling commissions, structuring fee, projected hedging profits, if any, estimated hedging costs and the closing price of one share of the underlying stock, including:
oany actual or potential change in our or JPMorgan Chase & Co.’s creditworthiness or credit spreads;
ocustomary bid-ask spreads for similarly sized trades;
oour internal secondary market funding rates for structured debt issuances;
othe actual and expected volatility in the prices of the underlying stock;
othe time to maturity of the securities;
owhether the closing price of one share of the underlying stock has been, or is expected to be, less than the downside threshold level on any determination date and whether the final stock price is expected to be less than the downside threshold level;
othe likelihood of an early redemption being triggered;
othe dividend rate on the underlying stock;
ointerest and yield rates in the market generally;
othe occurrence of certain events affecting the issuer of the underlying stock that may or may not require an adjustment to the stock adjustment factor, including a merger or acquisition; and
oa variety of other economic, financial, political, regulatory and judicial events.

Additionally, independent pricing vendors and/or third party broker-dealers may publish a price for the securities, which may also be reflected on customer account statements. This price may be different (higher or lower) than the price of the securities, if any, at which JPMS may be willing to purchase your securities in the secondary market.

Risks Relating to the Underlying Stock

■Investing in the securities is not equivalent to investing in the underlying stock. Investors in the securities will not have voting rights or rights to receive dividends or other distributions or any other rights with respect to the underlying stock.
■No affiliation with Amgen Inc. Amgen Inc. is not an affiliate of ours, is not involved with this offering in any way, and has no obligation to consider your interests in taking any corporate actions that might affect the value of the securities. We have not made any due diligence inquiry with respect to Amgen Inc. in connection with this offering.
■We may engage in business with or involving Amgen Inc. without regard to your interests. We or our affiliates may presently or from time to time engage in business with Amgen Inc. without regard to your interests and thus may acquire non-public information about Amgen Inc. Neither we nor any of our affiliates undertakes to disclose any such information to you. In addition, we or our affiliates from time to time have published and in the future may publish research reports with respect to Amgen Inc., which may or may not recommend that investors buy or hold the underlying stock.
■The anti-dilution protection for the underlying stock is limited and may be discretionary. The calculation agent will make adjustments to the stock adjustment factor and other adjustments for certain corporate events affecting the

April 2021Page 12

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

underlying stock. However, the calculation agent will not make an adjustment in response to all events that could affect the underlying stock. If an event occurs that does not require the calculation agent to make an adjustment, the value of the securities may be materially and adversely affected. You should also be aware that the calculation agent may make adjustments in response to events that are not described in the accompanying product supplement to account for any diluting or concentrative effect, but the calculation agent is under no obligation to do so or to consider your interests as a holder of the securities in making these determinations.

April 2021Page 13

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

 

Amgen Inc. Overview

Amgen Inc. discovers, develops, manufactures and delivers human therapeutics. The underlying stock is registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and is listed on The NASDAQ Stock Market. Information provided to or filed with the SEC by Amgen Inc. pursuant to the Exchange Act can be located by reference to the SEC file number 001-37702 through the SEC’s website at www.sec.gov.

Information as of market close on April 1, 2021:

Bloomberg Ticker Symbol: AMGN 52 Week High (on 7/20/2020): $260.95
Current Closing Price: $249.17 52 Week Low (on 4/1/2020): $197.81
52 Weeks Ago (on 4/1/2020): $197.81    

 

The table below sets forth the published high and low closing prices of, as well as dividends on, the underlying stock for each quarter in the period from January 1, 2016 through April 1, 2021. The closing price of the underlying stock on April 1, 2021 was $249.17. The associated graph shows the closing prices of the underlying stock for each day in the same period. We obtained the closing price information above and the information in the table and graph below from the Bloomberg Professional® service (“Bloomberg”), without independent verification. The closing prices may have been adjusted by Bloomberg for corporate actions such as stock splits, public offerings, mergers and acquisitions, spin-offs, delistings and bankruptcy.

Since its inception, the closing price of the underlying stock has experienced significant fluctuations. The historical performance of the underlying stock should not be taken as an indication of its future performance, and no assurance can be given as to the price of the underlying stock at any time, including on the determination dates.

Common Stock of Amgen Inc. High Low Close

Dividends

(Declared)

2016        

First Quarter $158.34 $140.90 $149.93 $1.00
Second Quarter $164.35 $144.58 $152.15 $1.00
Third Quarter $175.62 $154.27 $166.81 $1.00
Fourth Quarter $168.31 $135.22 $146.21 $1.15

2017        

First Quarter $182.60 $150.73 $164.07 $1.15
Second Quarter $174.07 $153.02 $172.23 $1.15
Third Quarter $191.00 $167.29 $186.45 $1.15
Fourth Quarter $188.59 $168.79 $173.90 $1.32

2018        

First Quarter $198.00 $169.43 $170.48 $1.32
Second Quarter $186.51 $166.05 $184.59 $1.32
Third Quarter $208.89 $185.29 $207.29 $1.32
Fourth Quarter $208.25 $178.40 $194.67 $1.45

2019        

First Quarter $203.88 $180.87 $189.98 $1.45
Second Quarter $195.41 $166.70 $184.28 $1.45
Third Quarter $208.62 $174.11 $193.51 $1.45
Fourth Quarter $243.20 $189.21 $241.07 $1.60

2020        

First Quarter $241.70 $182.24 $202.73 $1.60
Second Quarter $242.74 $197.81 $235.86 $1.60
Third Quarter $260.95 $234.65 $254.16 $1.60
Fourth Quarter $257.67 $216.38 $229.92 $1.76

 

April 2021Page 14

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

 

2021        

First Quarter $258.60 $221.91 $248.81 $1.76
Second Quarter (April 1, 2021) $249.17 $249.17 $249.17 —

We make no representation as to the amount of dividends, if any, that Amgen Inc. may pay in the future. In any event, as an investor in the securities, you will not be entitled to receive dividends, if any, that may be payable on the underlying stock.

 

The Common Stock of Amgen Inc. – Daily Closing Prices*
January 4, 2016 to April 1, 2021

 
*The dotted line in the graph indicates the downside threshold level, equal to 80% of the initial stock price.

This document relates only to the securities offered hereby and does not relate to the underlying stock or other securities of Amgen Inc. We have derived all disclosures contained in this document regarding the underlying stock from the publicly available documents described in the first paragraph under this “Amgen Inc. Overview” section without independent verification. In connection with the offering of the securities, neither we nor the agent has participated in the preparation of such documents or made any due diligence inquiry with respect to Amgen Inc. Neither we nor the agent makes any representation that such publicly available documents or any other publicly available information regarding Amgen Inc. is accurate or complete. Furthermore, we cannot give any assurance that all events occurring prior to the date hereof (including events that would affect the accuracy or completeness of the publicly available documents described in the first paragraph under this “Amgen Inc. Overview” section) that would affect the trading price of the underlying stock (and therefore the price of the underlying stock at the time we priced the securities) have been publicly disclosed. Subsequent disclosure of any such events or the disclosure of or failure to disclose material future events concerning Amgen Inc. could affect the value received at maturity with respect to the securities and therefore the trading prices of the securities.

Neither we nor any of our affiliates makes any representation to you as to the performance of the underlying stock.

April 2021Page 15

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

Additional Information about the Securities

Please read this information in conjunction with the summary terms on the front cover of this document.

 

Additional Provisions  
Record date: The record date for each contingent payment date is the date one business day prior to that contingent payment date.
Postponement of maturity date: If the scheduled maturity date is not a business day, then the maturity date will be the following business day.  If the scheduled final determination date is not a trading day or if a market disruption event occurs on that day so that the final determination date is postponed and falls less than three business days prior to the scheduled maturity date, the maturity date of the securities will be postponed to the third business day following that final determination date as postponed.
Minimum ticketing size: $1,000/100 securities
Trustee: Deutsche Bank Trust Company Americas (formerly Bankers Trust Company)
Calculation agent: JPMS
The estimated value of the securities:

The estimated value of the securities set forth on the cover of this document is equal to the sum of the values of the following hypothetical components: (1) a fixed-income debt component with the same maturity as the securities, valued using the internal funding rate described below, and (2) the derivative or derivatives underlying the economic terms of the securities. The estimated value of the securities does not represent a minimum price at which JPMS would be willing to buy your securities in any secondary market (if any exists) at any time. The internal funding rate used in the determination of the estimated value of the securities may differ from the market-implied funding rate for vanilla fixed income instruments of a similar maturity issued by JPMorgan Chase & Co. or its affiliates. Any difference may be based on, among other things, our and our affiliates’ view of the funding value of the securities as well as the higher issuance, operational and ongoing liability management costs of the securities in comparison to those costs for the conventional fixed income instruments of JPMorgan Chase & Co. This internal funding rate is based on certain market inputs and assumptions, which may prove to be incorrect, and is intended to approximate the prevailing market replacement funding rate for the securities. The use of an internal funding rate and any potential changes to that rate may have an adverse effect on the terms of the securities and any secondary market prices of the securities. For additional information, see “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Securities — The estimated value of the securities is derived by reference to an internal funding rate” in this document. The value of the derivative or derivatives underlying the economic terms of the securities is derived from internal pricing models of our affiliates. These models are dependent on inputs such as the traded market prices of comparable derivative instruments and on various other inputs, some of which are market-observable, and which can include volatility, dividend rates, interest rates and other factors, as well as assumptions about future market events and/or environments. Accordingly, the estimated value of the securities on the pricing date is based on market conditions and other relevant factors and assumptions existing at that time. See “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Securities — The estimated value of the securities does not represent future values of the securities and may differ from others’ estimates” in this document.

The estimated value of the securities is lower than the original issue price of the securities because costs associated with selling, structuring and hedging the securities are included in the original issue price of the securities. These costs include the selling commissions paid to JPMS and other affiliated or unaffiliated dealers, the structuring fee, the projected profits, if any, that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the securities and the estimated cost of hedging our obligations under the securities. Because hedging our obligations entails risk and may be influenced by market forces beyond our control, this hedging may result in a profit that is more or less than expected, or it may result in a loss. A portion of the profits, if any, realized in hedging our obligations under the securities may be allowed to other affiliated or unaffiliated dealers, and we or one or more of our affiliates will retain any remaining hedging profits. See “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Securities — The estimated value of the securities is lower than the original issue price (price to public) of the securities” in this document.

Secondary market prices of the securities: For information about factors that will impact any secondary market prices of the securities, see “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Securities — Secondary market prices of the securities will be impacted by many economic and market factors” in this document. In addition, we generally expect that some of the costs included in the original issue price of the securities will be partially paid back to you in connection with any repurchases of your securities by JPMS in an amount that will decline to zero over an initial predetermined period that is intended to be the shorter of two years and one-half of the stated term of the securities.  The length of any such initial period reflects the structure of the securities, whether our affiliates expect to earn a profit in connection with our hedging activities, the estimated costs of hedging the securities and when these costs are incurred, as determined by our affiliates.  See “Risk Factors — Risks Relating to the

April 2021Page 16

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

 

  Estimated Value and Secondary Market Prices of the Securities — The value of the securities as published by JPMS (and which may be reflected on customer account statements) may be higher than the then-current estimated value of the securities for a limited time period.”
Tax considerations:

You should review carefully the section entitled “Material U.S. Federal Income Tax Consequences” in the accompanying product supplement no. MS-1-II. In determining our reporting responsibilities we intend to treat (i) the securities for U.S. federal income tax purposes as prepaid forward contracts with associated contingent coupons and (ii) any contingent quarterly payments as ordinary income, as described in the section entitled “Material U.S. Federal Income Tax Consequences — Tax Consequences to U.S. Holders — Notes Treated as Prepaid Forward Contracts with Associated Contingent Coupons” in the accompanying product supplement. Based on the advice of Davis Polk & Wardwell LLP, our special tax counsel, we believe that this is a reasonable treatment, but that there are other reasonable treatments that the IRS or a court may adopt, in which case the timing and character of any income or loss on the securities could be materially affected. In addition, in 2007 Treasury and the IRS released a notice requesting comments on the U.S. federal income tax treatment of “prepaid forward contracts” and similar instruments. The notice focuses in particular on whether to require investors in these instruments to accrue income over the term of their investment. It also asks for comments on a number of related topics, including the character of income or loss with respect to these instruments and the relevance of factors such as the nature of the underlying property to which the instruments are linked. While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially affect the tax consequences of an investment in the securities, possibly with retroactive effect. The discussions above and in the accompanying product supplement do not address the consequences to taxpayers subject to special tax accounting rules under Section 451(b) of the Code. You should consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the securities, including possible alternative treatments and the issues presented by the notice described above.

Non-U.S. Holders — Tax Considerations. The U.S. federal income tax treatment of contingent quarterly payments is uncertain, and although we believe it is reasonable to take a position that contingent quarterly payments are not subject to U.S. withholding tax (at least if an applicable Form W-8 is provided), a withholding agent may nonetheless withhold on these payments (generally at a rate of 30%, subject to the possible reduction of that rate under an applicable income tax treaty), unless income from your securities is effectively connected with your conduct of a trade or business in the United States (and, if an applicable treaty so requires, attributable to a permanent establishment in the United States). If you are not a United States person, you are urged to consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the securities in light of your particular circumstances.

Section 871(m) of the Code and Treasury regulations promulgated thereunder (“Section 871(m)”) generally impose a 30% withholding tax (unless an income tax treaty applies) on dividend equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial instruments linked to U.S. equities or indices that include U.S. equities. Section 871(m) provides certain exceptions to this withholding regime, including for instruments linked to certain broad-based indices that meet requirements set forth in the applicable Treasury regulations. Additionally, a recent IRS notice excludes from the scope of Section 871(m) instruments issued prior to January 1, 2023 that do not have a delta of one with respect to underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an “Underlying Security”). Based on certain determinations made by us, our special tax counsel is of the opinion that Section 871(m) should not apply to the securities with regard to Non-U.S. Holders. Our determination is not binding on the IRS, and the IRS may disagree with this determination. Section 871(m) is complex and its application may depend on your particular circumstances, including whether you enter into other transactions with respect to an Underlying Security. You should consult your tax adviser regarding the potential application of Section 871(m) to the securities.

In the event of any withholding on the securities, we will not be required to pay any additional amounts with respect to amounts so withheld.

Supplemental use of proceeds and hedging:

The securities are offered to meet investor demand for products that reflect the risk-return profile and market exposure provided by the securities. See “How the Securities Work” in this document for an illustration of the risk-return profile of the securities and “Amgen Inc. Overview” in this document for a description of the market exposure provided by the securities.

The original issue price of the securities is equal to the estimated value of the securities plus the selling commissions paid to JPMS and other affiliated or unaffiliated dealers and the structuring fee, plus (minus) the projected profits (losses) that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the securities, plus the estimated cost of hedging our obligations under the securities.

Benefit plan investor considerations: See “Benefit Plan Investor Considerations” in the accompanying product supplement
Supplemental plan of distribution:

Subject to regulatory constraints, JPMS intends to use its reasonable efforts to offer to purchase the securities in the secondary market, but is not required to do so. JPMS, acting as agent for JPMorgan

 

April 2021Page 17

 

JPMorgan Chase Financial Company LLC

 

Contingent Income Auto-Callable Securities due April 4, 2024
Based on the Performance of the Common Stock of Amgen Inc.
Principal at Risk Securities

 

 

 

Financial, will pay all of the selling commissions it receives from us to Morgan Stanley Wealth Management. In addition, Morgan Stanley Wealth Management will receive a structuring fee as set forth on the cover of this document for each security.

We or our affiliate may enter into swap agreements or related hedge transactions with one of our other affiliates or unaffiliated counterparties in connection with the sale of the securities and JPMS and/or an affiliate may earn additional income as a result of payments pursuant to the swap or related hedge transactions. See “— Supplemental use of proceeds and hedging” above and “Use of Proceeds and Hedging” in the accompanying product supplement.

We expect that delivery of the securities will be made against payment for the securities on or about the original issue date set forth on the front cover of this document, which will be the third business day following the pricing date of the securities (this settlement cycle being referred to as “T+3”). Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in two business days, unless the parties to that trade expressly agree otherwise. Accordingly, purchasers who wish to trade securities on any date prior to two business days before delivery will be required to specify an alternate settlement cycle at the time of any such trade to prevent a failed settlement and should consult their own advisors.

Validity of the securities and the guarantee: In the opinion of Davis Polk & Wardwell LLP, as special products counsel to JPMorgan Financial and JPMorgan Chase & Co., when the securities offered by this pricing supplement have been executed and issued by JPMorgan Financial and authenticated by the trustee pursuant to the indenture, and delivered against payment as contemplated herein, such securities will be valid and binding obligations of JPMorgan Financial and the related guarantee will constitute a valid and binding obligation of JPMorgan Chase & Co., enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses no opinion as to (i) the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above or (ii) any provision of the indenture that purports to avoid the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law by limiting the amount of JPMorgan Chase & Co.’s obligation under the related guarantee.  This opinion is given as of the date hereof and is limited to the laws of the State of New York, the General Corporation Law of the State of Delaware and the Delaware Limited Liability Company Act.  In addition, this opinion is subject to customary assumptions about the trustee’s authorization, execution and delivery of the indenture and its authentication of the securities and the validity, binding nature and enforceability of the indenture with respect to the trustee, all as stated in the letter of such counsel dated February 26, 2020, which was filed as an exhibit to the Registration Statement on Form S-3 by JPMorgan Financial and JPMorgan Chase & Co. on February 26, 2020.

Where you can find more information:

You should read this document together with the accompanying prospectus, as supplemented by the accompanying prospectus supplement, relating to our Series A medium-term notes of which these securities are a part, and the more detailed information contained in the accompanying product supplement.

This document, together with the documents listed below, contains the terms of the securities and supersedes all other prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, stand-alone fact sheets, brochures or other educational materials of ours. You should carefully consider, among other things, the matters set forth in the “Risk Factors” sections of the accompanying prospectus supplement and the accompanying product supplement, as the securities involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisers before you invest in the securities.

You may access these documents on the SEC website at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):

· Product supplement no. MS-1-II dated November 4, 2020:

http://www.sec.gov/Archives/edgar/data/19617/000095010320021469/crt_dp139325-424b2.pdf

· Prospectus supplement and prospectus, each dated April 8, 2020:

http://www.sec.gov/Archives/edgar/data/19617/000095010320007214/crt_dp124361-424b2.pdf

Our Central Index Key, or CIK, on the SEC website is 1665650, and JPMorgan Chase & Co.’s CIK is 19617.

As used in this document, “we,” “us,” and “our” refer to JPMorgan Financial.

April 2021Page 18

 

 

 GRAPHIC 2 image_004.jpg GRAPHIC begin 644 image_004.jpg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end GRAPHIC 3 image_005.jpg GRAPHIC begin 644 image_005.jpg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�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end GRAPHIC 4 image_006.jpg GRAPHIC begin 644 image_006.jpg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end GRAPHIC 5 image_009.jpg GRAPHIC begin 644 image_009.jpg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end